Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9498744rdf:typepubmed:Citationlld:pubmed
pubmed-article:9498744lifeskim:mentionsumls-concept:C0011616lld:lifeskim
pubmed-article:9498744lifeskim:mentionsumls-concept:C0123759lld:lifeskim
pubmed-article:9498744lifeskim:mentionsumls-concept:C2698599lld:lifeskim
pubmed-article:9498744lifeskim:mentionsumls-concept:C0567416lld:lifeskim
pubmed-article:9498744lifeskim:mentionsumls-concept:C0104998lld:lifeskim
pubmed-article:9498744lifeskim:mentionsumls-concept:C1704410lld:lifeskim
pubmed-article:9498744lifeskim:mentionsumls-concept:C1413243lld:lifeskim
pubmed-article:9498744lifeskim:mentionsumls-concept:C1366561lld:lifeskim
pubmed-article:9498744lifeskim:mentionsumls-concept:C1705431lld:lifeskim
pubmed-article:9498744lifeskim:mentionsumls-concept:C1555029lld:lifeskim
pubmed-article:9498744lifeskim:mentionsumls-concept:C0443211lld:lifeskim
pubmed-article:9498744lifeskim:mentionsumls-concept:C0392760lld:lifeskim
pubmed-article:9498744pubmed:issue5lld:pubmed
pubmed-article:9498744pubmed:dateCreated1998-3-18lld:pubmed
pubmed-article:9498744pubmed:abstractTextCutaneous painting with reactive haptens induces contact sensitivity (CS) responses that are in vivo examples of T cell immunity. In contrast, high dose i.v. administration of the hapten can induce tolerance. We investigated the effect of IL-12 on reversal of this tolerance and attempted to determine in vitro the mechanism of this reversing effect by measuring proliferation and IFN-gamma production by CS effector T cells stimulated with hapten-conjugated APC, and we also measured CS ear swelling in vivo. The in vitro responses of T cells to hapten-APC became absent in tolerized mice, paralleling impaired in vivo CS responses. Addition of IL-12 to cultures manifesting this fully established in vitro tolerance completely restored impaired responses of tolerized T cells. The reversing effects of IL-12 were not blocked by anti-IFN-gamma mAb, but were blocked by mAbs against B7-1, more strongly by anti-B7-2, and by both Abs together. Additional in vivo ear-swelling response experiments confirmed the reversing effects of IL-12 on established tolerance. To examine whether the IL-12 effect depended on stimulation of IFN-gamma, we directly injected IFN-gamma into tolerized mice. This partially mimicked but did not fully reconstitute the effects of IL-12. In summary, IL-12 abrogation of established tolerance of CS may have been partially due to endogenous production of IFN-gamma, but appeared mainly due to direct activation of the tolerized T cells by affecting signaling through costimulatory molecules B7-1 and B7-2.lld:pubmed
pubmed-article:9498744pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9498744pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9498744pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9498744pubmed:languageenglld:pubmed
pubmed-article:9498744pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9498744pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9498744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9498744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9498744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9498744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9498744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9498744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9498744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9498744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9498744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9498744pubmed:statusMEDLINElld:pubmed
pubmed-article:9498744pubmed:monthMarlld:pubmed
pubmed-article:9498744pubmed:issn0022-1767lld:pubmed
pubmed-article:9498744pubmed:authorpubmed-author:MatsudaHHlld:pubmed
pubmed-article:9498744pubmed:authorpubmed-author:AskenaseP WPWlld:pubmed
pubmed-article:9498744pubmed:authorpubmed-author:KawamotoKKlld:pubmed
pubmed-article:9498744pubmed:authorpubmed-author:UshioHHlld:pubmed
pubmed-article:9498744pubmed:authorpubmed-author:SzczepanikMMlld:pubmed
pubmed-article:9498744pubmed:authorpubmed-author:TsujiR FRFlld:pubmed
pubmed-article:9498744pubmed:issnTypePrintlld:pubmed
pubmed-article:9498744pubmed:day1lld:pubmed
pubmed-article:9498744pubmed:volume160lld:pubmed
pubmed-article:9498744pubmed:ownerNLMlld:pubmed
pubmed-article:9498744pubmed:authorsCompleteYlld:pubmed
pubmed-article:9498744pubmed:pagination2080-8lld:pubmed
pubmed-article:9498744pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:meshHeadingpubmed-meshheading:9498744-...lld:pubmed
pubmed-article:9498744pubmed:year1998lld:pubmed
pubmed-article:9498744pubmed:articleTitleIL-12 reverses established antigen-specific tolerance of contact sensitivity by affecting costimulatory molecules B7-1 (CD80) and B7-2 (CD86).lld:pubmed
pubmed-article:9498744pubmed:affiliationDepartment of Veterinary Surgery, University of Osaka Prefecture College of Agriculture, Japan.lld:pubmed
pubmed-article:9498744pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9498744pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9498744lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9498744lld:pubmed